Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Nexoptic Technology Corp V.NXO

Alternate Symbol(s):  NXOPF

NexOptic Technology Corp. is a Canada-based technology company. The Company is engaged in developing artificial intelligence (AI) and imaging products, which enhance how images are either captured, processed, experienced, transferred and/or stored. It is developing technologies relating to imagery and light concentration for lens and image capture systems. The Company's primary focus is its... see more

TSXV:NXO - Post Discussion

Nexoptic Technology Corp > I challenge this board
View:
Post by Damn1212 on Feb 11, 2022 10:51am

I challenge this board

I challenge this board and more specifically Barstoole 

to provide 1 time NXO said they were expecting revenue ... 

They never have , because of course when they fxck us all out of our money they will say we are a research company and never promised revenue or sales as per below. 

Forward-looking statements are based on the then current expectations, beliefs, assumptions, estimates and forecasts about the business and the industry and markets in which the Company operates and are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations, including, among others: risks commonly associated with the development of new technologies, including the Company’s AI technologies, sport optics product designs and additional work may be required to confirm potential applications and feasibility of such technologies or for the successful commercialization of its offerings; the Company may not be able to complete product development as currently expected; potential applications of the Company’s technology are based on limited studies and may not be representative of the broader market; the risk that all designs may not achieve expected results; the Company may not be able to reach commercial success;
Comment by DonRudy on Feb 11, 2022 12:40pm
Potential revenue to be expected in 2022 through Nexoptic partnerships. I believe pristine surgical stated a release their endoscope in the first half of 2022. Flexwatch security cameras across Asia Pacific through Jeteson platform.  Continuing to wait and see if anything materializes through 2022. The continued waiting game. 
Comment by Damn1212 on Feb 11, 2022 12:57pm
@ DON  Please provide the mentioned proof of your statement , this is just your speculation as NXO has never ever once mentioned or asserted they expect revenue in 2022 or ever.  I belive pristine surgical ... :>?  ummm I asked for NXO mentioning  revenue ...  Please provide 1 example where NXO mentions revenue or sales now or in future ?  Not 1 is available ...more  
Comment by Auenboy0 on Feb 11, 2022 1:33pm
"Pristine Surgical and Nexoptic reach commercial agreement" I believe was a headline. It's my understanding a commercial agreement is indicative of coming revenue. While I have you, do you really own the 2.1 million shares you've boasted, and if so, are you the dumbest person you know? One of two things happen, this company is smoke, mirrors and does nothing with its announced ...more  
Comment by Damn1212 on Feb 11, 2022 1:41pm
Ohh Auenboy I ask for NXO statement on them producing revenue ...  Can you provide one ?  Pristine surgical doesnt even have any sales    Please im waiting !  In the mean time here is what they say on every single news release   The reader is cautioned that forward-looking statements are not guarantees of future performance and involve known and unknown ...more  
Comment by DonRudy on Feb 11, 2022 1:38pm
@Damn, the pristine surgical projection came from an hour long video describing their endoscopy device. At one point they asked when they were planning to have their product ready. At that point they stated first half of 2022.  Nexoptic didn't provide that guidance, pristine surgical did. Will it come to fruition, we will have to see.  Flexwatch can be found in a previous NR ...more  
Comment by Damn1212 on Feb 11, 2022 1:45pm
@ Don  my challenge was very specific  Can someone produce any evidence NXO plans on generating any revenue or sales Now or anytime in the future .  You want to get a NR of pristine surgical in the discussion.  1 . Pristine is not NXO  2. Pristine has 0 products available at the moment.  Again , I challenge all the board to provide 1 piece of evidence !  ...more  
Comment by DonRudy on Feb 11, 2022 1:52pm
Damn, I posted a post regarding potential revenue for 2022 through pristine and flexwatch. The most likely from the information we have. I don't care what your post specifically, or requests you have for myself and others.  Your copy and paste is a standard disclaimer used by all pre rev companies.  you are absolutely right. Nexoptic has never provided guidance and you may ...more  
Comment by Damn1212 on Feb 11, 2022 2:11pm
Great Don  So we agree ?  NXO has never ever provided any formal intention that they will today or anytime in the future produce revenue !  See, you guys get upset and throw insults when you realize the reality.  But but ... Pristine said this ...  But but Flex said this ...  Its odd that your anger is towards me and not the company that decieved us all. 
Comment by DonRudy on Feb 11, 2022 2:20pm
Damn, it's not that I'm angry at you, I just find myself shaking my head. If you're not happy with the performance of any investment, it's time to take control and adjust accordingly.  Revenue was the topic. So I simply stated some information that's out regarding partnerships and potential revenue that could come this year. Either lower your exposure, or exit all ...more  
Comment by Damn1212 on Feb 11, 2022 2:28pm
Hey Don  Thanks for the post.  Im confident the share price will raise again dont get me wrong.  Its a bit weird though a company would exist with no guidance on sales.  just my opinion 
Comment by DonRudy on Feb 11, 2022 2:38pm
I believed we would be further along with revenue and guidance at this point.  As nothing is certain and anyone still hanging can't do much but wait and see.  I'm looking to Flexwatch and pristine to be potential first revenue.  But that's simply a guess.  Nexoptic has a terrible track record, though being in a better position today than the days of double ...more  
Comment by AUborealis on Feb 11, 2022 2:43pm
If you're looking for 'guidance on earnings' ...take a rest (please) ...until they have 4 quarters of revenues/sales ...which means at least one year or more from now. Until then you're wasting your breath ....and cluttering the board with your petulence.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities